Lee:Literature Transporters: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 9: Line 9:


==Transporters general review==
==Transporters general review==
<biblio>
# Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications.Pharm Res. 2007 Oct;24(10):1803-23. (pmid=17404808)
#1 pmid=17404808
# Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009 Dec;50(12):2340-57. (pmid=19498215)
#2 pmid=19498215  
# pmid=16119972
#3 pmid=16119972
 
</biblio>
==OATP family general review==
==OATP family general review==
<biblio>  
<biblio>  

Revision as of 07:45, 4 January 2011

Home                  Research                  Lab Members                  Publications                  JC                      Links                  Internal                  Contact                 

Feel free to add articles ...

Transporters general review

  1. Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications.Pharm Res. 2007 Oct;24(10):1803-23. (pmid=17404808)
  2. Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009 Dec;50(12):2340-57. (pmid=19498215)
  3. pmid=16119972

OATP family general review

  1. Hagenbuch B and Meier PJ. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 2004 Feb;447(5):653-65. DOI:10.1007/s00424-003-1168-y | PubMed ID:14579113 | HubMed [1]
  2. Niemi M. Role of OATP transporters in the disposition of drugs. Pharmacogenomics. 2007 Jul;8(7):787-802. DOI:10.2217/14622416.8.7.787 | PubMed ID:18240907 | HubMed [2]
All Medline abstracts: PubMed | HubMed

OATP1B3

  1. Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, and Matsuno S. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99. DOI:10.1053/gast.2001.24804 | PubMed ID:11375950 | HubMed [1]
  2. Gui C and Hagenbuch B. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. Biochemistry. 2008 Sep 2;47(35):9090-7. DOI:10.1021/bi8008455 | PubMed ID:18690707 | HubMed [2]
  3. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, and Tsuji A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. DOI:10.1006/bbrc.2000.2922 | PubMed ID:10873595 | HubMed [3]
  4. Vavricka SR, Jung D, Fried M, Grützner U, Meier PJ, and Kullak-Ublick GA. The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. J Hepatol. 2004 Feb;40(2):212-8. DOI:10.1016/j.jhep.2003.10.008 | PubMed ID:14739090 | HubMed [4]
  5. Muto M, Onogawa T, Suzuki T, Ishida T, Rikiyama T, Katayose Y, Ohuchi N, Sasano H, Abe T, and Unno M. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci. 2007 Oct;98(10):1570-6. DOI:10.1111/j.1349-7006.2007.00570.x | PubMed ID:17760952 | HubMed [5]
  6. Hamada A, Sissung T, Price DK, Danesi R, Chau CH, Sharifi N, Venzon D, Maeda K, Nagao K, Sparreboom A, Mitsuya H, Dahut WL, and Figg WD. Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res. 2008 Jun 1;14(11):3312-8. DOI:10.1158/1078-0432.CCR-07-4118 | PubMed ID:18519758 | HubMed [6]
  7. Ohtsuka H, Abe T, Onogawa T, Kondo N, Sato T, Oshio H, Mizutamari H, Mikkaichi T, Oikawa M, Rikiyama T, Katayose Y, and Unno M. Farnesoid X receptor, hepatocyte nuclear factors 1alpha and 3beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene. J Gastroenterol. 2006 Apr;41(4):369-77. DOI:10.1007/s00535-006-1784-3 | PubMed ID:16741617 | HubMed [7]
  8. Sharifi N, Hamada A, Sissung T, Danesi R, Venzon D, Baum C, Gulley JL, Price DK, Dahut WL, and Figg WD. A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int. 2008 Aug 5;102(5):617-21. DOI:10.1111/j.1464-410X.2008.07629.x | PubMed ID:18537956 | HubMed [8]
  9. Gui C, Miao Y, Thompson L, Wahlgren B, Mock M, Stieger B, and Hagenbuch B. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur J Pharmacol. 2008 Apr 14;584(1):57-65. DOI:10.1016/j.ejphar.2008.01.042 | PubMed ID:18321482 | HubMed [9]
  10. Yamaguchi H, Kobayashi M, Okada M, Takeuchi T, Unno M, Abe T, Goto J, Hishinuma T, and Mano N. Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes. Cancer Lett. 2008 Feb 18;260(1-2):163-9. DOI:10.1016/j.canlet.2007.10.040 | PubMed ID:18082941 | HubMed [10]
  11. Mahagita C, Grassl SM, Piyachaturawat P, and Ballatori N. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G271-8. DOI:10.1152/ajpgi.00075.2007 | PubMed ID:17412826 | HubMed [11]
  12. Komatsu M, Furukawa T, Ikeda R, Takumi S, Nong Q, Aoyama K, Akiyama S, Keppler D, and Takeuchi T. Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3. Toxicol Sci. 2007 Jun;97(2):407-16. DOI:10.1093/toxsci/kfm054 | PubMed ID:17369605 | HubMed [12]
  13. Monks NR, Liu S, Xu Y, Yu H, Bendelow AS, and Moscow JA. Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells. Mol Cancer Ther. 2007 Feb;6(2):587-98. DOI:10.1158/1535-7163.MCT-06-0500 | PubMed ID:17308056 | HubMed [13]
  14. Smith NF, Marsh S, Scott-Horton TJ, Hamada A, Mielke S, Mross K, Figg WD, Verweij J, McLeod HL, and Sparreboom A. Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics. Clin Pharmacol Ther. 2007 Jan;81(1):76-82. DOI:10.1038/sj.clpt.6100011 | PubMed ID:17186002 | HubMed [14]
  15. Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, and Marin JJ. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?. J Biol Chem. 2006 Oct 13;281(41):30326-35. DOI:10.1074/jbc.M602048200 | PubMed ID:16877380 | HubMed [15]
  16. Ichihara S, Kikuchi R, Kusuhara H, Imai S, Maeda K, and Sugiyama Y. DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines. Pharm Res. 2010 Mar;27(3):510-6. DOI:10.1007/s11095-010-0064-3 | PubMed ID:20130966 | HubMed [16]
  17. Maeda T, Irokawa M, Arakawa H, Kuraoka E, Nozawa T, Tateoka R, Itoh Y, Nakanishi T, and Tamai I. Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer. J Steroid Biochem Mol Biol. 2010 Oct;122(4):180-5. DOI:10.1016/j.jsbmb.2010.06.014 | PubMed ID:20615467 | HubMed [17]
  18. Glaeser H, Mandery K, Sticht H, Fromm MF, and König J. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3. Br J Pharmacol. 2010 Feb 1;159(3):698-708. DOI:10.1111/j.1476-5381.2009.00568.x | PubMed ID:20100277 | HubMed [18]
  19. van de Steeg E, Wagenaar E, van der Kruijssen CM, Burggraaff JE, de Waart DR, Elferink RP, Kenworthy KE, and Schinkel AH. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest. 2010 Aug;120(8):2942-52. DOI:10.1172/JCI42168 | PubMed ID:20644253 | HubMed [19]
All Medline abstracts: PubMed | HubMed

P-glycoprotein (MDR1)

  1. Aszalos A. Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) I. Preclinical aspects. Drug Discov Today. 2007 Oct;12(19-20):833-7. DOI:10.1016/j.drudis.2007.07.022 | PubMed ID:17933684 | HubMed [1]
  2. Aszalos A. Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. Drug Discov Today. 2007 Oct;12(19-20):838-43. DOI:10.1016/j.drudis.2007.07.021 | PubMed ID:17933685 | HubMed [2]
  3. Marchetti S, Mazzanti R, Beijnen JH, and Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007 Aug;12(8):927-41. DOI:10.1634/theoncologist.12-8-927 | PubMed ID:17766652 | HubMed [3]
All Medline abstracts: PubMed | HubMed

bile acid signaling

  1. Donnellan F, Keating N, Geoghegan P, Murray FE, Harvey BJ, and Keely SJ. JNK mitogen-activated protein kinase limits calcium-dependent chloride secretion across colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G37-44. DOI:10.1152/ajpgi.00202.2009 | PubMed ID:19875701 | HubMed [1]
  2. Cáceres M, Tobar N, Guerrero J, Smith PC, and Martínez J. c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway. J Cell Biochem. 2008 Feb 15;103(3):986-93. DOI:10.1002/jcb.21469 | PubMed ID:17654528 | HubMed [2]
  3. Sommerfeld A, Reinehr R, and Häussinger D. Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem. 2009 Aug 14;284(33):22173-22183. DOI:10.1074/jbc.M109.005355 | PubMed ID:19553664 | HubMed [3]
  4. Takeuchi K, Shin-ya T, Nishio K, and Ito F. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. FEBS J. 2009 Mar;276(5):1255-65. DOI:10.1111/j.1742-4658.2008.06861.x | PubMed ID:19175673 | HubMed [4]
  5. Ding G, Zhang A, Huang S, Pan X, Zhen G, Chen R, and Yang T. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am J Physiol Renal Physiol. 2007 Dec;293(6):F1889-97. DOI:10.1152/ajprenal.00112.2007 | PubMed ID:17881465 | HubMed [5]
  6. Reinehr R, Becker S, Wettstein M, and Häussinger D. Involvement of the Src family kinase yes in bile salt-induced apoptosis. Gastroenterology. 2004 Nov;127(5):1540-57. DOI:10.1053/j.gastro.2004.08.056 | PubMed ID:15521021 | HubMed [6]
  7. Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, and Dent P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell. 2001 Sep;12(9):2629-45. DOI:10.1091/mbc.12.9.2629 | PubMed ID:11553704 | HubMed [7]
  8. Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, and Gores GJ. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology. 2002 Apr;122(4):985-93. DOI:10.1053/gast.2002.32410 | PubMed ID:11910351 | HubMed [8]
  9. Chen K, Vita JA, Berk BC, and Keaney JF Jr. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem. 2001 May 11;276(19):16045-50. DOI:10.1074/jbc.M011766200 | PubMed ID:11278982 | HubMed [9]
  10. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, Amorino G, Valerie K, Sealy L, Engelhardt JF, Grant S, Hylemon PB, and Dent P. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol. 2003 May;23(9):3052-66. DOI:10.1128/MCB.23.9.3052-3066.2003 | PubMed ID:12697808 | HubMed [10]
  11. Zucchini-Pascal N, de Sousa G, Pizzol J, and Rahmani R. Pregnane X receptor activation protects rat hepatocytes against deoxycholic acid-induced apoptosis. Liver Int. 2010 Feb;30(2):284-97. DOI:10.1111/j.1478-3231.2009.02108.x | PubMed ID:19737350 | HubMed [11]
All Medline abstracts: PubMed | HubMed
Retrieved from "https://openwetware.org/mediawiki/index.php?title=Lee:Literature_Transporters&oldid=483294"